All In Biotech

Drug Trial Radar · NCT07141394

Coordinated Access for Addiction Recovery and Equity in VA Supportive Housing

Coordinated Access for Addiction Recovery and Equity in VA Supportive Housing (CARE-VASH) (QUE 25-013)

Last checked: Nov 20, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitationPivotal-lookingRandomized with 7,908 participants. This is a heuristic, not a regulatory label.

Status

Enrolling by invitation

Enrollment

7,908

Planned (sponsor's estimate)

Start

Sep 15, 2026

Primary completion

Sep 30, 2030

Study completion Sep 30, 2030

Sponsor

Lead sponsor
VA Office of Research and DevelopmentFederal agency
Sponsor type
Federal agency
Collaborators
University of California, Los Angeles
First posted
Aug 26, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The Department of Housing and Urban Development-VA Supportive Housing (HUD-VASH) Program provides subsidized permanent housing with case management to homeless-experienced Veterans (HEVs). Up to 40% of Veterans exit HUD-VASH within two years of attaining housing; substance use disorders (SUDs) are one of the largest causes of returns to homelessness for HEVs. CARE-VASH QUERI proposes to implement and evaluate two evidence-based SUD services - Medications for addiction treatment (MAT) and cognitive behavioral therapy for SUDs (CBT-SUD) - among Veterans in HUD-VASH.

Conditions

  • Homelessness
  • Substance Use Disorder (SUD)

Interventions

  • Medication for Addiction Treatment (MAT)Drug

    MAT includes medications for alcohol use disorder (MAUD) and medications for opioid use disorder (MAUD). It reduces substance use, increases SUD treatment engagement, enhances quality of life, and reduces overdoses.

  • Cognitive Behavioral Therapy for Substance Use Disorders (CBT-SUD)Behavioral

    An evidence-based psychotherapy that uses cognitive behavioral therapy to further recovery goals across SUD diagnoses.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Reach of MAT (Medications for Addiction Treatment)Time frame: 18 months post-implementation
  2. Reach of CBT-SUD (Cognitive Behavioral Therapy-Substance Use Disorders)Time frame: 18 months post-implementation
  3. Adoption of MAT (Medications for Addiction Treatment)Time frame: 18 months post-implementation
  4. Adoption of CBT-SUD (Cognitive Behavioral Therapy-Substance Use Disorders)Time frame: 18 months post-implementation
  5. Sustainment of MAT (Medications for Addiction Treatment)Time frame: 18-27 months post-implementation
  6. Sustainment of CBT-SUD (Cognitive Behavioral Therapy-Substance Use Disorders)Time frame: 18-27 months post-implementation

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA

    West Los Angeles, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.